Browse the complete Report on: Drug Delivery Markets Oral Delivery

Browse All Kalorama Information Reports at Kalorama Information

Since our last edition of this report in 2007, The oral drug delivery market is the largest segment of the drug delivery market, and there’s no sign that it is slowing down. With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products, and seeking to tap into the growing elderly population that requires products with a level of ease-of-use and cost benefit, it’s no surprise that the oral delivery drug market is a $35 billion industry and expected to grow as much as ten percent per year.

Kalorama’s Drug Delivery Markets: Oral Delivery provides the definitive break down of the market for oral delivery drug markets. The report covers both the major technologies in oral delivery (controlled-release, delayed release, pulsatile-release, taste-masked and microemulsion formulations) and the products that use these delivery technologies.

In the reporting of market size and growth through 2013, Kalorama’s unique analysis breaks out separates the value of the technology portion of the market from the active ingriedient portion of the market, allowing for a deeper understanding of the value of the market attributable to the delivery technologies themselves.

This focused report provides information on the revenues for relevant companies and provides information critical to assessing the opportunities available in this market, including:

• Legacy Companies in Oral Delivery as well as Recent Entrants
• Current World Wide Revenue Across Product Categories and Future Forecasts
• Revenues by Combonent and by Component ( Pharmaceutical vs. Technology portion of Revenue) Type of Delivery (Timed Release vs. Other)
• Challenges Faced by Oral-Delivery Technology Companies
• Success Stories and Pitfalls
• The Trends That are Expected to Lead to Global Growth

Kalorama’s trusted information-gathering process provides most accurate study of the oral delivery drug market available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the industry. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.
Product managers, marketing managers, business development executives, advertising agency or investment firm executives, and information and research center librarians are among the individuals who will find this report on the oral delivery drug market essential.

About Us
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Contact: 

Ms. Sunita

7557 Rambler road,

Suite 727, Dallas, TX 75231

Tel: +1-888-989-8004

http://reportsandreports.blogspot.com/ 

http://reportsandreports.proarticles.co.uk/ 

http://reportsnreports.wordpress.com/

Browse the complete Report on: Drug Delivery Markets Implantable Injectable and Needle Free Delivery Systems

Browse All Kalorama Information Reports at Kalorama Information

With pharmaceutical companies increasingly looking for ways to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the industry. Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems provides detail for business planners on the market for implantable / injectable delivery system markets.

Biopharmaceutical products are driving growth of needle-free systems; there will likely be significant increases in revenues in the vaccine arena. This report looks at that trend and reports current and forecasted revenues for the implantable/injectable drug delivery market, segmented into two main categories:

• Needle-free drug delivery
• Other Injectable/Implantable

Kalorama's unique analysis offers segmentation of this market for:

• Drug Delivery Techology Revenues
• Pharmaceuticals Sold via Delivery Technology

This breakout makes the report relevant to business plans of either device technology companies or pharmaceutical concerns. (This market analysis does not include drug-eluding stents or prefilled or regular syringes. Kalorama considers these seperate markets)

With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the pharmaceutical industry.

Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems, the second volume of Kalorama’s popular series focusing on global drug delivery systems markets, provides the definitive break down of the market for implantable / injectable delivery system markets. The report covers both pharmaceuticals sold through implantable/injectable delivery systems and the technologies themselves including:

This focused report provides information on the revenues for relevant companies and provides information critical to assessing the opportunities available in this market, including:

• Detailed Profiles of Key Companies in Implantable/Injectable Delivery and Brief Round-Up of smaller players
• Current Market Size and Forecasts to 2013
• Needle-Free Cost Savings, Protein-Coated Microcrystal Technology, Nanotechnology, and Other Trends and Developments
• New Products in Development

Kalorama’s trusted information-gathering process provides most accurate study of the implantable/injectable delivery drug market available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the industry. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.

Companies Profiled in the report include:

• Alkermes, Inc.
• ALZA Corp.
• Antares Pharma, Inc.
• Bioject Medical Technologies, Inc.
• CyDex, Inc.
• MGI Pharma, Inc
• Nektar Therapeutics
• Pacira Pharmaceuticals, Inc.
• pSivida
• SurModics, Inc
• Zogenix Corporation
• AP Pharma
• Baxter BioPharma Solutions
• QLT USA, Inc
• Ypsomed Holding AG

Kalorama has also published Drug Delivery Markets: Oral Delivery, which details markets for oral technology enhancements which have increased drug product sales and extended patent life.

About Us
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Contact: 

Ms. Sunita

7557 Rambler road,

Suite 727, Dallas, TX 75231

Tel: +1-888-989-8004

http://reportsandreports.blogspot.com/ 

http://reportsandreports.proarticles.co.uk/ 

http://reportsnreports.wordpress.com/